Implant shows promise in reducing heavy drinking days
NCT ID NCT07333638
Summary
This study tested whether a small, implanted pellet of the medication naltrexone could help adults with moderate to severe alcohol use disorder reduce their drinking. 210 participants received either a low-dose implant, a high-dose implant, or a placebo implant, along with counseling. Researchers tracked their drinking habits and safety for up to 48 weeks to see if the implant was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Xiangya Hospital of Central South University Address: No. 139, Renmin Road Central, Changsha City
Changsha, Hunan, 410011, China
Conditions
Explore the condition pages connected to this study.